Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
41
SLP Quote, Financials, Valuation and Earnings
Last price:
$12.79
Seasonality move
:
5.61%
Day range:
$12.85 - $13.70
52-week range:
$12.85 - $44.27
Dividend yield:
1.86%
P/E ratio:
49.91x
P/S ratio:
3.25x
P/B ratio:
2.10x
Volume:
1.7M
Avg. volume:
790.4K
1-year change:
-70.82%
Market cap:
$259.8M
Revenue:
$70M
EPS (TTM):
-$3.15
Earnings Data
Next earnings date for SLP
Oct 23
2025
Most recent earnings per share
-$3.35
Missed by $3.60
(Jul 14/2025)
Consensus Estimate
$0.25
(Jul 14/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SLP Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 10/23/2025 | Q3 | $16.5M | -- | -- | $0.06 | -- |
| 07/14/2025 | Q2 | $19.6M | $20.4M | -$3.35 | $0.25 | -$3.60 |
| 04/03/2025 | Q1 | $21.9M | $22.4M | $0.15 | $0.26 | -$0.11 |
| 01/07/2025 | Q4 | $18.8M | $18.9M | $0.01 | $0.17 | -$0.16 |
| 10/23/2024 | Q3 | $19.7M | $18.7M | $0.04 | $0.06 | -$0.02 |
| 07/02/2024 | Q2 | $17.9M | $18.5M | $0.15 | $0.16 | -$0.01 |
| 04/03/2024 | Q1 | $17.3M | $18.3M | $0.20 | $0.18 | $0.02 |
| 01/03/2024 | Q4 | -- | -- | $0.10 | $0.11 | -$0.01 |
| 10/25/2023 | Q3 | -- | -- | $0.03 | -- | -- |
| 07/06/2023 | Q2 | -- | -- | $0.20 | $0.21 | -$0.01 |
| 04/05/2023 | Q1 | -- | -- | $0.20 | $0.18 | $0.02 |
| 01/04/2023 | Q4 | -- | -- | $0.06 | $0.10 | -$0.04 |
| 10/26/2022 | Q3 | -- | -- | $0.04 | $0.09 | -$0.05 |
| 07/06/2022 | Q2 | -- | -- | $0.20 | $0.17 | $0.03 |
| 04/06/2022 | Q1 | -- | -- | $0.21 | $0.12 | $0.09 |
| 01/06/2022 | Q4 | -- | -- | $0.15 | $0.09 | $0.06 |
| 10/25/2021 | Q3 | -- | -- | $0.01 | $0.09 | -$0.08 |
| 07/12/2021 | Q2 | -- | -- | $0.18 | $0.18 | -- |
| 04/12/2021 | Q1 | -- | -- | $0.15 | $0.14 | $0.01 |
| 01/11/2021 | Q4 | -- | -- | $0.12 | $0.11 | $0.01 |
| 11/16/2020 | Q3 | -- | -- | $0.11 | $0.10 | $0.01 |
| 07/09/2020 | Q2 | -- | -- | $0.16 | $0.06 | $0.10 |
| 02/29/2020 | Q1 | -- | -- | $0.12 | -- | -- |
| 11/30/2019 | Q4 | -- | -- | $0.11 | -- | -- |
| 08/31/2019 | Q3 | -- | -- | -- | -- | -- |
| 04/10/2017 | Q1 | -- | -- | -- | $0.08 | -- |
| 01/09/2017 | Q4 | -- | -- | $0.08 | $0.07 | $0.01 |
| 11/11/2016 | Q3 | -- | -- | $0.05 | $0.04 | $0.01 |
| 07/14/2016 | Q2 | -- | -- | $0.11 | $0.12 | -$0.01 |
| 04/13/2016 | Q1 | -- | -- | $0.07 | $0.07 | -- |
| 01/14/2016 | Q4 | -- | -- | $0.06 | $0.05 | $0.01 |
| 11/19/2015 | Q3 | -- | -- | $0.03 | $0.02 | $0.01 |
Simulations Plus Earnings Questions
-
How Much did Simulations Plus Generate in Revenue Last Quarter?
Simulations Plus reported $20.4M worth of top line sales in its most recent quarter.
-
Did Simulations Plus Beat Earnings Last Quarter?
Simulations Plus announced earnings per share of -$3.35 which represents a miss of analyst forecast a $0.25 per share.
-
Is Simulations Plus Profitable?
Simulations Plus reported $13M that represents $0.65 per share over the last quarter.
-
What is the Analyst Consensus for Simulations Plus EPS Next Year?
Simulations Plus's earnings are forecast to grow from $0.49 per share to $0.55 per share next year representing an increase of 101.02%.
-
When is Simulations Plus's Earnings Date?
Simulations Plus's next earnings date is October 23, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
